RAGE, diabetes, and the nervous system - PubMed (original) (raw)
Review
RAGE, diabetes, and the nervous system
Cory Toth et al. Curr Mol Med. 2007 Dec.
Abstract
Longstanding diabetes mellitus targets kidney, retina, and blood vessels, but its impact upon the nervous system is another important source of disability. Diabetic peripheral neuropathy is a serious complication of inadequately treated diabetes leading to sensory loss, intractable neuropathic pain, loss of distal leg muscles, and impairment of balance and gait. Diabetes has been implicated as a cause of brain atrophy, white matter abnormalities, and cognitive impairment and a risk factor for dementia. Recent studies have incriminated advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic nervous system complications. The availability of RAGE knockout mice and a competitive decoy for AGEs, soluble RAGE (sRAGE), has advanced our knowledge of the RAGE-mediated signalling pathways within the nervous system. They also provide hope for a future novel intervention for the prevention of diabetes-associated neurological complications. This review will discuss current knowledge of diabetes- and RAGE-mediated neurodegeneration, involving the distal-most level of epidermal nerve fibers in skin, major peripheral nerve trunks, dorsal root ganglia, spinal cord, and brain.
Similar articles
- RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.
Juranek JK, Geddis MS, Song F, Zhang J, Garcia J, Rosario R, Yan SF, Brannagan TH, Schmidt AM. Juranek JK, et al. Diabetes. 2013 Mar;62(3):931-43. doi: 10.2337/db12-0632. Epub 2012 Nov 19. Diabetes. 2013. PMID: 23172920 Free PMC article. - Role of advanced glycation end products in diabetic neuropathy.
Sugimoto K, Yasujima M, Yagihashi S. Sugimoto K, et al. Curr Pharm Des. 2008;14(10):953-61. doi: 10.2174/138161208784139774. Curr Pharm Des. 2008. PMID: 18473845 Review. - Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW. Toth C, et al. Diabetes. 2008 Apr;57(4):1002-17. doi: 10.2337/db07-0339. Epub 2007 Nov 26. Diabetes. 2008. PMID: 18039814 Retracted. - Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S, Matsui T, Nakamura K. Yamagishi S, et al. Curr Drug Targets. 2007 Oct;8(10):1138-43. doi: 10.2174/138945007782151298. Curr Drug Targets. 2007. PMID: 17979674 Review. - Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S, Nakamura K, Matsui T, Noda Y, Imaizumi T. Yamagishi S, et al. Curr Pharm Des. 2008;14(5):487-95. doi: 10.2174/138161208783597416. Curr Pharm Des. 2008. PMID: 18289075 Review.
Cited by
- Flavonols as a Potential Pharmacological Intervention for Alleviating Cognitive Decline in Diabetes: Evidence from Preclinical Studies.
Horvat A, Vlašić I, Štefulj J, Oršolić N, Jazvinšćak Jembrek M. Horvat A, et al. Life (Basel). 2023 Nov 30;13(12):2291. doi: 10.3390/life13122291. Life (Basel). 2023. PMID: 38137892 Free PMC article. Review. - New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review.
Raghav A, Singh M, Jeong GB, Giri R, Agarwal S, Kala S. Raghav A, et al. Front Endocrinol (Lausanne). 2022 Oct 27;13:1036220. doi: 10.3389/fendo.2022.1036220. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387914 Free PMC article. Review. - Protective Effects and Possible Mechanisms of Ergothioneine and Hispidin against Methylglyoxal-Induced Injuries in Rat Pheochromocytoma Cells.
Song TY, Yang NC, Chen CL, Thi TLV. Song TY, et al. Oxid Med Cell Longev. 2017;2017:4824371. doi: 10.1155/2017/4824371. Epub 2017 Oct 17. Oxid Med Cell Longev. 2017. PMID: 29181125 Free PMC article. - Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.
Chen PM, Gregersen H, Zhao JB. Chen PM, et al. World J Diabetes. 2015 May 15;6(4):662-72. doi: 10.4239/wjd.v6.i4.662. World J Diabetes. 2015. PMID: 25987965 Free PMC article. - Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.
Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Calcutt NA, et al. Nat Rev Drug Discov. 2009 May;8(5):417-29. doi: 10.1038/nrd2476. Nat Rev Drug Discov. 2009. PMID: 19404313 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical